iStock / Getty Images Plus

Congressman Demands To Know Why FDA Hasn't Approved Generic Insulin

Rep. Mike Kelly says prices have jumped 600% since 2001

July 16, 2019 - 4:45 pm

PITTSBURGH (Newsradio 1020 KDKA) - With some diabetic patients paying between $120 and $400 a month for insulin, Pittsburgh area Congressman Mike Kelly has written the Food and Drug Administration demanding to know why it hasn't approved generic versions.

“We want to know specifically what is holding up the merchandizing and putting on the shelf a generic that would dramatically cut the cost for people who need insulin every day,” said Kelly.

Kelly is diabetic and says the price of insulin has risen 600 percent since 2001.

Some experts say generic insulin is more expensive to make than other generics and so there is less incentive.

Three drug makers control 90 percent of the global insulin market.

Follow KDKA Radio: Facebook | Twitter | Instagram
Listen to KDKA Radio on the App - Download Now